Please login to the form below

Not currently logged in
Email:
Password:

leukaemia

This page shows the latest leukaemia news and features for those working in and with pharma, biotech and healthcare.

Daiichi starts challenging Astellas for Japanese AML market

Vanflyta is for patients with relapsed/refractory acute myeloid leukaemia. Daiichi Sankyo has begun selling Vanflyta (quizartinib) in Japan for use in patients with relapsed/refractory FLT3-ITD acute myeloid leukaemia

Latest news

More from news
Approximately 72 fully matching, plus 381 partially matching documents found.

Latest Intelligence

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    An 11-month old baby suffering from CD19-positive acute lymphoblastic leukaemia (ALL) was treated with modified donor T cells that had been engineered to attack leukaemia cells.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    as myelodysplastic syndrome (MDS), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML) and solid tumours. ... are ineligible for intensive chemotherapy, to go along with its existing indications in chronic lymphocytic leukaemia (CLL).

  • Deal Watch October 2018

    AstraZeneca. Anti-NKG2A antibody (monalizumab), IPH5201 (antibody targeting CD38) and Lumoxiti. #. for hairy cell leukaemia. Development &. commercialisation. collaboration. $307m. ViraTherapeutics/. Boehringer Ingelheim. ... Manufacture and supply of

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    Novartis’ leukaemia treatment Glivec.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    The field is marching on rapidly. Studies of checkpoint inhibitors are now taking place in less common forms of cancer with greater unmet needs, such as gastric cancer, acute myelocytic leukaemia ... antigen receptor T-cell (CAR-T) therapies from

More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics